ORCL
Oracle CorporationClose $178.34EOD onlyThis page reflects ORCL options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.
Historical consensus-supported lens with full content, report chain context, and metric rail.
Outlook
Moderately bullish: dealer short-gamma hedging and net-buy flow support continuation toward resistance band (~185–190); pinning risk from max-pain near 150–155 can compress upside if momentum fades.
Conflicts: Spot distance above MP and max‑pain pins at 150–155; limited nearby gamma protection if selling resumes.
Regime Classification
Price Range Forecast
Key Levels
Dealer Positioning (GEX/DEX)
GEX: $+276.4M
DEX: +68.0M shares
Gamma flip: N/A
NTM gamma: GEX +$276.4M, dex +68M shares — dealers net short gamma and short delta exposure; hedging entails buying into rallies (support) and selling into drops (pin risk).
IV Analysis
IV vs VIX: Ticker IV richer than index VIX—options pricier than broad market, favoring directional hedged exposure over naked premium selling.
Term structure: Elevated near‑term IV with mild roll‑off; no major scheduled event kinks in next 2 weeks.
Skew: Put concentration below spot creates skew; consider directional call structures or defined flies to limit pin risk.
Flow Analysis
Net premium: Net premium ~+45.3M (positive = net premium received by sellers). This implies market-wide selling pressure (supports bullish delta if sellers are short calls), but interpretation depends on buy/sell-to-open split—confirm BTO/STO to know if premium was paid or collected.
Directional prints: 13.3 call 177.5 OTM 2026-04-17 — Very large intraday call block (23k vol, OI 2.9k) — likely aggressive call buying or large seller compression into close; bullish if BTO, bearish if STO. 6.8 put 175 OTM 2026-04-17 — Heavy same-day put volume (28k vol, OI 4k) — could be hedging or directional selling; side unclear without BTO/STO.
Unusual: 54.5 put 140 OTM 2026-05-22 — Very high vol/OI ratio on long-dated 140 puts — flags unusual activity but does not reveal trade-side; need block/BTO/STO records to infer directional exposure. 49.2 put 180 ITM 2026-04-24 — Elevated vol/OI at 180 puts indicating uncommon flow; cannot assume buyer direction without trade-side confirmation.
Risks & Catalysts
Strategy Viability
| Strategy | Edge | Best Setup | Primary Risk |
|---|---|---|---|
| Put credit spread | Moderate-Strong | Sell 2026-06-18 $160.00/$155.00 put spread Why now: Moderately bullish bias, dealer short-gamma and buy flow support upside; defined-risk premium sale monetizes elevated IV and net premium. | Pinning or momentum fade re-tests 155; sudden IV spike widens put prices. |
| Bull call spread | Moderate | Buy 2026-06-18 $185.00/$190.00 call spread Why now: Directional bullish lean with target into resistance band; debit spread controls cost while retaining upside exposure through earnings. | If momentum stalls or IV compresses post-earnings, spread may underperform; capped upside. |
| Put credit spread | Moderate-Strong | Sell 2026-05-15 $160.00/$155.00 put spread Why now: Moderately bullish bias with dealer short-gamma and net-buy flow; sell downside premium near max-pain band to earn yield if momentum continues. | IV spike or momentum reversal into 160–155 max-pain can force mark-to-market losses. |
| Bull call spread | Moderate | Buy 2026-05-15 $170.00/$175.00 call spread Why now: Directional long conviction over multi-week horizon; defined debit spread reduces cost vs naked call and benefits from rollable vega profile. | Limited upside if momentum stalls; moderate theta decay on long leg before move. |
| Call diagonal | Moderate-Strong | Sell 2026-05-01 $175.00 call / buy 2026-06-18 $180.00 call Why now: Sell rich May near-term call (compression risk) and buy June call to keep upside exposure across earnings window if needed. | Near-term IV crush or large directional gap vs sold strike; calendar can flip if vol term-structure inverts. |
| Cash-secured put | Moderate | Sell 2026-06-18 $160.00 cash-secured put Why now: Moderately bullish and willing to own shares near 155; choose post-earnings expiry to avoid forced unwind if thesis expects follow-through through earnings. | Assignment into broader market weakness or IV rise; capital tie-up until expiration. |
Top Plays
Watchlist Triggers
Tactical Summary
Read the Directional analysis for ORCL for 2026-04-17. Each report is a market-close snapshot with regime read, key levels, and strategy context that translates options positioning into an actionable setup.